Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

about

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

Item

http://www.wikidata.org/entity/Q58765251

description

scientific article published on 04 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@en

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@nl

type

Item

label

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@en

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@nl

prefLabel

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@en

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@nl

P1476

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

@en

P2093

Hong Ma

http://www.w3.org/2001/XMLSchema#string

Honglei Weng

http://www.w3.org/2001/XMLSchema#string

Roman Liebe

http://www.w3.org/2001/XMLSchema#string

Shuzhen Wang

http://www.w3.org/2001/XMLSchema#string

Tao Han

http://www.w3.org/2001/XMLSchema#string

Wen Xie

http://www.w3.org/2001/XMLSchema#string

Xin Zhang

http://www.w3.org/2001/XMLSchema#string

Yonggang Li

http://www.w3.org/2001/XMLSchema#string

P2860

Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Oral tolvaptan is safe and effective in chronic hyponatremia

Clinical efficacy of tolvaptan for treatment of refractory ascites in liver cirrhosis patients

The treatment of vasopressin V2-receptor antagonists in cirrhosis patients with ascites: a meta-analysis of randomized controlled trials.

Prediction of diuretic response to tolvaptan by a simple, readily available spot urine Na/K ratio.

Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents.

Tolvaptan: a new tool for the effective treatment of hyponatremia in psychotic disorders.

Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis.

Cirrhotic ascites review: Pathophysiology, diagnosis and management.

Predictive parameter of tolvaptan effectiveness in cirrhotic ascites.

P2888

s12876-018-0857-0

P304

137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12876-018-0857-0

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hui-Guo Ding

P577

2018-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106630069

http://www.w3.org/2001/XMLSchema#string

P698

30180806

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

P932

6123923

http://www.w3.org/2001/XMLSchema#string